journal article·2021-09

Synthesis of pH-sensitive hyaluronic acid nanogels loaded with paclitaxel and interferon gamma: Characterization and effect on the A549 lung carcinoma cell line

Nima Faraji, Ali Esrafili, Behnaz Esfandiari, Arash Abednezhad, Mohammad Naghizadeh, Javad Arasteh

Publisher page

Abstract

Lung cancer is one of the deadliest cancers in various populations. Apart from the effects that anticancer drugs such as paclitaxel (PTX) have on cancer cells, they also have many side effects on healthy cells. Interferon gamma (IFN-γ) is also one of the cytokines used in the treatment of cancer. Current research is focused on providing new drug carriers to find new therapeutic goals. After synthesis of nanogels and loading of PTX and IFN-γ, the cytotoxicity of these nanogels on A549 and HEK293 healthy cell line was measured by MTT assay and flow cytometry analysis. Finally, the expression of STAT1 gene was investigated using Real time-PCR. The results of MTT assay showed that the survival rate of healthy cells treated with PTX and IFN-γ-loaded nanogels was 2.15 and 2.39 times higher than cancer cells, respectively. The results also showed that the gene expression STAT1 in A549 cells exposed to these nanogels was higher than healthy cells (p < 0.05). Based on flow cytometry results, the death rate of healthy cells treated with the mentioned nanogels was lower than cancer cells (p < 0.05). Therefore, Studies showed that synthesized nanogels have positive effects on cancer cells and also have fewer side effects on healthy cells.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Lung Cancer Research Studies · Immune cells in cancer · Chemokine receptors and signaling

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (39)

Show source-provided references
1. Small-cell lung cancer: what we know, what we need to know and the path forward10.1038/nrc.2017.87 ↗
2. Non-small-cell lung cancer10.1038/nrdp.2015.9 ↗
3. Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy10.1016/j.ejpb.2015.03.018 ↗
4. Adjuvant or neoadjuvant chemotherapy for NSCLC
5. Adjuvant and neoadjuvant cancer therapies: a historical review and a rational approach to understand outcomes10.1053/j.seminoncol.2019.01.002 ↗
6. How Taxol/paclitaxel kills cancer cells10.1091/mbc.e14-04-0916 ↗
7. Paclitaxel’s mechanistic and clinical effects on breast cancer10.3390/biom9120789 ↗
8. Cytokines in clinical cancer immunotherapy10.1038/s41416-018-0328-y ↗
9. Cytokines in the treatment of cancer10.1089/jir.2018.0019 ↗
10. Cytokines in clinical cancer immunotherapy10.1038/s41416-018-0328-y ↗
11. Cytokines in Cancer immunotherapy10.3390/cancers3043856 ↗
12. Cytokines in the treatment of cancer10.1089/jir.2018.0019 ↗
13. Interferon-gamma at the crossroads of tumor immune surveillance or evasion
14. Interferon gamma in cancer immunotherapy10.1002/cam4.1700 ↗
15. The EPR effect and beyond: strategies to improve tumor targeting and cancer nanomedicine treatment efficacy10.7150/thno.49577 ↗
16. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy
17. Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine10.1155/2019/3702518 ↗
18. Nanoscale drug delivery for targeted chemotherapy10.1016/j.canlet.2016.05.023 ↗
19. Basic concepts and recent advances in nanogels as carriers for medical applications10.1080/10717544.2016.1276232 ↗
20. Polymeric nanogels as drug delivery systems
21. Polysaccharide based nanogels in the drug delivery system: application as the carrier of pharmaceutical agents
22. Hyaluronan: a simple polysaccharide with diverse biological functions10.1016/j.actbio.2013.12.019 ↗
23. CD44, a therapeutic target for metastasising tumours10.1016/j.ejca.2010.02.024 ↗
24. The biology and role of CD44 in cancer progression: therapeutic implications10.1186/s13045-022-01287-3 ↗
25. Development and application of hyaluronic acidin tumor targeting drug delivery10.1016/j.apsb.2019.06.004 ↗
26. Hyaluronic acid for anticancer drug and nucleic acid delivery
27. Synthesis of polymeric nano/microgels: a review10.1007/s10965-017-1281-9 ↗
28. Hyaluronic acid-based pH-sensitive nanogels for tumor targeted drug delivery
29. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition10.1038/s41598-018-19930-w ↗
30. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method10.1006/meth.2001.1262 ↗
31. Use of infrared spectroscopy to monitor protein structure and stability10.1586/14789450.2.5.731 ↗
32. Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancertherapy: in vitro and in vivo analysis10.1016/j.ijbiomac.2014.08.054 ↗
33. Acid–degradable carboxymethyl chitosan nanogels via an ortho ester linkage mediated improved penetration and growth inhibition of 3-D tumor spheroids in vitro10.1016/j.msec.2017.04.098 ↗
34. Hydrotropic hyaluronic acid conjugates: synthesis, characterization,and implications as a carrier of paclitaxel
35. Injectable hyaluronic acid-tyramine hydrogels incorporating interferon-α2a for liver cancer therapy10.1016/j.jconrel.2013.01.008 ↗
36. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment10.2147/IJN.S155383 ↗
37. STAT1 in cancer: friend or foe?
38. STAT1: a modulator of chemotherapy-induced apoptosis10.1158/0008-5472.CAN-04-1864 ↗
39. Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases10.1126/science.278.5343.1630 ↗